141 related articles for article (PubMed ID: 35012326)
1. Adjunctive Ketamine With Relapse Prevention-Based Psychological Therapy in the Treatment of Alcohol Use Disorder.
Grabski M; McAndrew A; Lawn W; Marsh B; Raymen L; Stevens T; Hardy L; Warren F; Bloomfield M; Borissova A; Maschauer E; Broomby R; Price R; Coathup R; Gilhooly D; Palmer E; Gordon-Williams R; Hill R; Harris J; Mollaahmetoglu OM; Curran HV; Brandner B; Lingford-Hughes A; Morgan CJA
Am J Psychiatry; 2022 Feb; 179(2):152-162. PubMed ID: 35012326
[TBL] [Abstract][Full Text] [Related]
2. A proof-of-concept investigation into ketamine as a pharmacological treatment for alcohol dependence: study protocol for a randomised controlled trial.
McAndrew A; Lawn W; Stevens T; Porffy L; Brandner B; Morgan CJ
Trials; 2017 Apr; 18(1):159. PubMed ID: 28372596
[TBL] [Abstract][Full Text] [Related]
3. A Single Ketamine Infusion Combined With Motivational Enhancement Therapy for Alcohol Use Disorder: A Randomized Midazolam-Controlled Pilot Trial.
Dakwar E; Levin F; Hart CL; Basaraba C; Choi J; Pavlicova M; Nunes EV
Am J Psychiatry; 2020 Feb; 177(2):125-133. PubMed ID: 31786934
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.
Daly EJ; Trivedi MH; Janik A; Li H; Zhang Y; Li X; Lane R; Lim P; Duca AR; Hough D; Thase ME; Zajecka J; Winokur A; Divacka I; Fagiolini A; Cubala WJ; Bitter I; Blier P; Shelton RC; Molero P; Manji H; Drevets WC; Singh JB
JAMA Psychiatry; 2019 Sep; 76(9):893-903. PubMed ID: 31166571
[TBL] [Abstract][Full Text] [Related]
5. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users.
Klimas J; Tobin H; Field CA; O'Gorman CS; Glynn LG; Keenan E; Saunders J; Bury G; Dunne C; Cullen W
Cochrane Database Syst Rev; 2014 Dec; (12):CD009269. PubMed ID: 25470303
[TBL] [Abstract][Full Text] [Related]
6. Couples relapse prevention sessions after behavioral marital therapy for male alcoholics: outcomes during the three years after starting treatment.
O'Farrell TJ; Choquette KA; Cutter HS
J Stud Alcohol; 1998 Jul; 59(4):357-70. PubMed ID: 9647418
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial.
Garbutt JC; Kampov-Polevoy AB; Gallop R; Kalka-Juhl L; Flannery BA
Alcohol Clin Exp Res; 2010 Nov; 34(11):1849-57. PubMed ID: 20662805
[TBL] [Abstract][Full Text] [Related]
8. Esketamine combined with a mindfulness-based intervention for individuals with alcohol problems.
Gent EM; Bryan JW; Cleary MA; Clarke TI; Holmwood HD; Nassereddine RO; Salway C; Depla S; Statton S; Krecké J; Morgan CJ
J Psychopharmacol; 2024 Jun; 38(6):541-550. PubMed ID: 38863284
[TBL] [Abstract][Full Text] [Related]
9. Ketamine-facilitated behavioral treatment for cannabis use disorder: A proof of concept study.
Azhari N; Hu H; O'Malley KY; Blocker ME; Levin FR; Dakwar E
Am J Drug Alcohol Abuse; 2021 Jan; 47(1):92-97. PubMed ID: 33175580
[TBL] [Abstract][Full Text] [Related]
10. Reduction of alcohol drinking in young adults by naltrexone: a double-blind, placebo-controlled, randomized clinical trial of efficacy and safety.
O'Malley SS; Corbin WR; Leeman RF; DeMartini KS; Fucito LM; Ikomi J; Romano DM; Wu R; Toll BA; Sher KJ; Gueorguieva R; Kranzler HR
J Clin Psychiatry; 2015 Feb; 76(2):e207-13. PubMed ID: 25742208
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.
Popova V; Daly EJ; Trivedi M; Cooper K; Lane R; Lim P; Mazzucco C; Hough D; Thase ME; Shelton RC; Molero P; Vieta E; Bajbouj M; Manji H; Drevets WC; Singh JB
Am J Psychiatry; 2019 Jun; 176(6):428-438. PubMed ID: 31109201
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial.
Dwyer JB; Landeros-Weisenberger A; Johnson JA; Londono Tobon A; Flores JM; Nasir M; Couloures K; Sanacora G; Bloch MH
Am J Psychiatry; 2021 Apr; 178(4):352-362. PubMed ID: 33653121
[TBL] [Abstract][Full Text] [Related]
13. A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder.
Feder A; Costi S; Rutter SB; Collins AB; Govindarajulu U; Jha MK; Horn SR; Kautz M; Corniquel M; Collins KA; Bevilacqua L; Glasgow AM; Brallier J; Pietrzak RH; Murrough JW; Charney DS
Am J Psychiatry; 2021 Feb; 178(2):193-202. PubMed ID: 33397139
[TBL] [Abstract][Full Text] [Related]
14. Alcoholics Anonymous and other 12-step programs for alcohol use disorder.
Kelly JF; Humphreys K; Ferri M
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD012880. PubMed ID: 32159228
[TBL] [Abstract][Full Text] [Related]
15. Learning to resist the urge: a double-blind, randomized controlled trial investigating alcohol-specific inhibition training in abstinent patients with alcohol use disorder.
Tschuemperlin RM; Stein M; Batschelet HM; Moggi F; Soravia LM
Trials; 2019 Jul; 20(1):402. PubMed ID: 31277683
[TBL] [Abstract][Full Text] [Related]
16. A Single Ketamine Infusion Combined With Mindfulness-Based Behavioral Modification to Treat Cocaine Dependence: A Randomized Clinical Trial.
Dakwar E; Nunes EV; Hart CL; Foltin RW; Mathew SJ; Carpenter KM; Choi CJJ; Basaraba CN; Pavlicova M; Levin FR
Am J Psychiatry; 2019 Nov; 176(11):923-930. PubMed ID: 31230464
[TBL] [Abstract][Full Text] [Related]
17. [A double blind placebo controlled randomized clinical trial of the efficacy and safety of pregabalin in induction of remission in patients with alcohol dependence].
Krupitsky EM; Rybakova KV; Skurat EP; Semenova NV; Neznanov NG
Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(1):33-43. PubMed ID: 32105267
[TBL] [Abstract][Full Text] [Related]
18. Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial.
Anderson IM; Blamire A; Branton T; Clark R; Downey D; Dunn G; Easton A; Elliott R; Elwell C; Hayden K; Holland F; Karim S; Loo C; Lowe J; Nair R; Oakley T; Prakash A; Sharma PK; Williams SR; McAllister-Williams RH;
Lancet Psychiatry; 2017 May; 4(5):365-377. PubMed ID: 28359862
[TBL] [Abstract][Full Text] [Related]
19. Sustained effectiveness and cost-effectiveness of Counselling for Alcohol Problems, a brief psychological treatment for harmful drinking in men, delivered by lay counsellors in primary care: 12-month follow-up of a randomised controlled trial.
Nadkarni A; Weiss HA; Weobong B; McDaid D; Singla DR; Park AL; Bhat B; Katti B; McCambridge J; Murthy P; King M; Wilson GT; Kirkwood B; Fairburn CG; Velleman R; Patel V
PLoS Med; 2017 Sep; 14(9):e1002386. PubMed ID: 28898239
[TBL] [Abstract][Full Text] [Related]
20. Comparison of acamprosate and placebo in long-term treatment of alcohol dependence.
Whitworth AB; Fischer F; Lesch OM; Nimmerrichter A; Oberbauer H; Platz T; Potgieter A; Walter H; Fleischhacker WW
Lancet; 1996 May; 347(9013):1438-42. PubMed ID: 8676626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
